- Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: a randomised phase II trialCarlos Gamboa-Vignolle
Department of Radiation Oncology, Instituto Nacional de Cancerología INCan, Mexico City, Mexico
Radiother Oncol 102:187-91. 2012..This randomised phase II study evaluated the use of Temozolomide (TMZ) concomitant with 30 Gray (Gy) of Whole-brain irradiation (WBI) for 2 weeks without adjuvant TMZ vs. WBI alone in patients with Brain metastases (BM) from solid tumours...
- Clinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancerFernando Lara-Medina
Departments of Medical Oncology, Instituto Nacional de Cancerologia, Mexico City, Mexico
Breast J 18:233-41. 2012..001). These factors can identify a subgroup of patients who are candidates for an intensive management approach...
- Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancerAlberto Alvarado-Miranda
Department of Medical Oncology, Instituto Nacional de Cancerologia, Mexico City, Mexico
Radiat Oncol 4:24. 2009..The aim of this study was to analyze in a retrospective manner the effectiveness of concurrent chemo-radiotherapy (CCRTh) after neoadjuvant chemotherapy (NCT) in patients with LABC...